Interaction of preS domains of hepatitis B virus with phospholipid vesicles

Biochimica et Biophysica Acta - Biomembranes

Volumn 1788, Issue 2, 2009, Pages 417-424

  Núñez, Elena ^a   Yélamos, Belén ^a   Delgado, Carmen ^a   Gómez Gutiérrez, Julián ^a   Peterson, Darrell L ^b   Gavilanes, Francisco ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fusion; HBV; Phospholipid membrane; preS domain

Indexed keywords

ENVELOPE PROTEIN; PHOSPHOLIPID;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DEPOLARIZATION; FLUORESCENCE; GENETIC CODE; HEPATITIS B VIRUS; NONHUMAN; PH; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; CIRCULAR DICHROISM; HEPATITIS B VIRUS; LIPOSOMES; MICROSCOPY, ELECTRON; MOLECULAR SEQUENCE DATA; PHOSPHOLIPIDS; PROTEIN BINDING; SPECTROMETRY, FLUORESCENCE; TEMPERATURE; VIRAL ENVELOPE PROTEINS;

HEPATITIS B VIRUS;

EID: 59249086605     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2008.10.014     Document Type: Article

References (40)

1. Neurath A.R., Kent S.B.H., Strick N., and Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46 (1986) 429-436
2. Machida A., Kishimoto S., and Ohnuma H. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 85 (1983) 268-274
3. Treichel U., Meyer zum Büschenfelde K.H., Dienes H.P., and Gerken G. Receptor-mediated entry of hepatitis B into liver cells. Arch. Virol. 142 (1997) 493-498
4. De Falco S., Ruvoletto M.G., Verdoliva A., Ruvo M., Raucci A., Marino M., Senatore S., Cassani G., Alberti A., Pontisso P., and Fassina G. Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J. Biol. Chem. 276 (2001) 36613-36623
5. Blanchet M., and Sureau C. Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues. J. Virol. 81 (2007) 5841-5849
6. Deng Q., Zhai J.W., Michel M.L., Zhang J., Qin J., Kong Y.Y., Zhang X.X., Budkowska A., Tiollais P., Wang Y., and Xie Y.H. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site. J. Virol. 81 (2007) 4244-4254
7. Rodríguez-Crespo I., Gómez-Gutierrez J., Nieto M., Peterson D.L., and Gavilanes F. Prediction of a putative fusion peptide in the S protein of the hepatitis B virus. J. Gen. Virol. 75 (1994) 637-639
8. Rodríguez-Crespo I., Núñez E., Gómez-Gutierrez J., Yélamos B., Albar J.P., Peterson D.L., and Gavilanes F. Phospholipid interactions of a putative fusion peptide of hepatitis B virus surface antigen S protein. J. Gen. Virol. 76 (1995) 301-308
9. Rodriguez-Crespo I., Gomez-Gutierrez J., Encinar J.A., Gonzalez-Ros J.M., Albar J.P., Peterson D.L., and Gavilanes F. Structural properties of the putative fusion peptide of hepatitis B virus upon interaction with phospholipids. Circular dichroism and Fourier-transform infrared spectroscopy studies. Eur. J. Biochem. 242 (1996) 243-248
10. Lu X., Block T.M., and Gerlich W.H. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J. Virol. 70 (1996) 2277-2285
11. Rodriguez-Crespo I., Nunez E., Yelamos B., Gomez-Gutierrez J., Albar J.P., Peterson D.L., and Gavilanes F. Fusogenic activity of hepadnavirus peptides corresponding to sequences downstream of the putative cleavage site. Virology 261 (1999) 133-142
12. Lu X., Hazboun T., and Block T. Limited proteolysis induces woodchuck hepatitis virus infectivity for human HepG2 cells. Virus Res. 73 (2001) 27-40
13. Nunez E., Wei X., Delgado C., Rodriguez-Crespo I., Yelamos B., Gomez-Gutierrez J., Peterson D.L., and Gavilanes F. Cloning, expression, and purification of histidine-tagged preS domains of hepatitis B virus. Protein Expr Purif. 21 (2001) 183-191
14. Rapaport D., and Shai Y. Interaction of fluorescently labeled pardaxin and its analogues with lipid bilayers. J. Biol. Chem. 266 (1991) 23769-23775
15. Schwarz G., Gerke H., Rizzo V., and Stankowski S. Incorporation kinetics in a membrane, studied with the pore-forming peptide alamethicin. Biophys. J. 52 (1987) 685-692
16. Ellens H., Bentz J., and Szoka F.C. H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry 24 (1985) 3099-3106
17. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
18. Perczel A., Hollósi M., Tusnády G., and Fasman G.D. Decovolution of the circular dichroism spectra of proteins: the circular dichroism spectra of antiparallel-sheet in proteins. Protein Eng. 4 (1991) 669-679
19. Pouny Y., Rapaport D., Mor A., Nicolas P., and Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry 31 (1992) 12416-12423
20. Rajarathnam K., Hochman J., Schindler M., and Ferguson-Miller S. Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes. Biochemistry 28 (1989) 3168-3176
21. Duzgunes N., Allen T.M., Fedor J., and Papahadjopoulos D. Lipid mixing during membrane aggregation and fusion: why fusion assays disagree. Biochemistry 26 (1987) 8435-8442
22. Blumenthal R., Henkart M., and Steer C.J. Clathrin-induced pH-dependent fusion of phosphatidylcholine vesicles. J. Biol. Chem. 258 (1983) 3409-3415
23. Ellens H., Bentz J., and Szoka F.C. pH-induced destabilization of phosphatidylethanolamine-containing liposomes: role of bilayer contact. Biochemistry 23 (1984) 1532-1538
24. Schwarz G., Stankowski S., and Rizzo V. Thermodynamic analysis of incorporation and aggregation in a membrane: application to the pore-forming peptide alamethicin. Biochim. Biophys. Acta 861 (1986) 141-151
25. Peled H., and Shai Y. Membrane interaction and self-assembly within phospholipid membranes of synthetic segments corresponding to the H-5 region of the shaker K+ channel. Biochemistry 32 (1993) 7879-7885
26. Papahadjopoulos D., Moscarello M., Eylar E.H., and Isac T. Effects of proteins on thermotropic phase transitions of phospholipid membranes. Biochim. Biophys. Acta 401 (1975) 317-335
27. Lentz B.R., Barenholz Y., and Thompson T.E. Fluorescence depolarization studies of phase transitions and fluidity in phospholipid bilayers. 2 Two-component phosphatidylcholine liposomes. Biochemistry 15 (1976) 4529-4537
28. Prendergast F.G., Haugland R.P., and Callahan P.J. 1-[4-(Trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties, and use as a fluorescence probe of lipid bilayers. Biochemistry 20 (1981) 7333-7338
29. Chernomordik L.V., Leikina E., Frolov V., Bronk P., and Zimmerberg J. An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids. J. Cell Biol. 136 (1997) 81-93
30. Puri A., Krumbiegel M., Dimitrov D., and Blumenthal R. A new approach to measure fusion activity of cloned viral envelope proteins: fluorescence dequenching of octadecylrhodamine-labeled plasma membrane vesicles fusing with cells expressing vesicular stomatitis virus glycoprotein. Virology 195 (1993) 855-858
31. Roux M., Nezil F.A., Monck M., and Bloom M. Fragmentation of phospholipid bilayers by myelin basic protein. Biochemistry 33 (1994) 307-311
32. Zimmerberg J., and McLaughlin S. Membrane curvature: how BAR domains bend bilayers. Curr. Biol. 14 (2004) R250-R252
33. Larsen C.E., Nir S., Alford D.R., Jennings M., Lee K.D., and Duzgunes N. Human immunodeficiency virus type 1 (HIV-1) fusion with model membranes: kinetic analysis and the role of lipid composition, pH and divalent cations. Biochim. Biophys. Acta 1147 (1993) 223-236
34. Doms R.W., Helenius A., and White J. Membrane fusion activity of the influenza virus hemagglutinin. The low pH-induced conformational change. J. Biol. Chem. 260 (1985) 2973-2981
35. Bullough P.A., Hughson F.M., Skehel J.J., and Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371 (1994) 37-43
36. Nieva J.L., Nir S., Muga A., Goni F.M., and Wilschut J. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry 33 (1994) 3201-3209
37. Epand R.M. Fusion peptides and the mechanism of viral fusion. Biochim. Biophys. Acta 1614 (2003) 116-121
38. Peisajovich S.G., and Shai Y. New insights into the mechanism of virus-induced membrane fusion. Trends Biochem. Sci. 27 (2002) 183-189
39. Pacheco B., Gomez-Gutierrez J., Yelamos B., Delgado C., Roncal F., Albar J.P., Peterson D., and Gavilanes F. Membrane-perturbing properties of three peptides corresponding to the ectodomain of hepatitis C virus E2 envelope protein. Biochim. Biophys. Acta 1758 (2006) 755-763
40. Lavillette D., Pecheur E.I., Donot P., Fresquet J., Molle J., Corbau R., Dreux M., Penin F., and Cosset F.L. Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J. Virol. 81 (2007) 8752-8765